Megan Raddatz
Nurse Practitioner · Cedar Rapids, IANPI 1255661864
Payments from drug & device makers
Across 110 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$354
- Pfizer$329
- Biogen$131
- Abbott$88
- Itamar Medical Inc$82
- Ipsen Biopharmaceuticals, Inc$78
- plus $932 from 32 others
What the payments were for
- Food & beverage$1,994100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $354 |
| Pfizer | 28 | $329 |
| Biogen | 6 | $131 |
| Abbott | 3 | $88 |
| Itamar Medical Inc | 2 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $78 |
| Johnson & Johnson(2 entities) | 3 | $78 |
| Lundbeck LLC | 3 | $66 |
| Argenx US, Inc. | 3 | $64 |
| Amgen(2 entities) | 2 | $48 |
| EMD Serono, Inc. | 2 | $45 |
| Genentech USA, Inc. | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $36 |
| TG Therapeutics, Inc. | 2 | $35 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Philips North America LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Novartis | 1 | $27 |
| Averitas Pharma Inc. | 1 | $27 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $25 |
| Neurelis, Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| 3b Medical, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Harmony Biosciences LLC | 1 | $19 |
| Catalyst Pharmaceuticals, Inc. | 1 | $19 |
| Avion Pharmaceuticals | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $17 |
| MDD US Operations, LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
How this compares
$1,994 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 12 | $102,315 |
| Nurtec OdtRimegepant Sulfate | 25 | $44,868 |
| UbrelvyUbrogepant | 20 | $26,368 |
| LamictalLamotrigine | 11 | $22,855 |
| Aimovig AutoinjectorErenumab-Aooe | 24 | $17,259 |
| KeppraLevetiracetam | 21 | $15,801 |
| Emgality PenGalcanezumab-Gnlm | 20 | $14,188 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 16 | $12,120 |
| Depakote ErDivalproex Sodium | 12 | $11,487 |
| Levetiracetam | 200 | $8,968 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 217 | $6,536 |
| Lamotrigine OdtLamotrigine | 13 | $5,609 |
| TegretolCarbamazepine | 12 | $5,309 |
| Divalproex Sodium ErDivalproex Sodium | 87 | $4,624 |
| Carbamazepine ErCarbamazepine | 67 | $4,236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenVumerity | $131 | $102,31512 claims |
| PfizerNurtec Odt | $329 | $44,86825 claims |
| AbbVieUbrelvy | $354 | $26,36820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in Iowa.
Other nurse practitioner in Cedar Rapids
- Megan Hart FernandezCedar Rapids$19K
- Carla HuberCedar Rapids$18K
- Katie MaybanksCedar Rapids$4K
- Sashi SolomonCedar Rapids$4K
- Paula StultzCedar Rapids$4K
- Sarah NorrisCedar Rapids$4K
- Melissa CoulterCedar Rapids$4K
- Margaret StracuzziCedar Rapids$4K
- Jessie LeeperCedar Rapids$3K
- Nicole MorganDes Moines$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.